Home
>
National Drug Code (NDC)
>
Naproxen
Naproxen - 21695-343-30 - (Naproxen)
Drug Information of Naproxen
| Product NDC: | 21695-343 |
| Proprietary Name: | Naproxen |
| Non Proprietary Name: | Naproxen |
| Active Ingredient(s): | 500 mg/1 & nbsp; Naproxen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Naproxen
| Product NDC: | 21695-343 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075227 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100602 |
Package Information of Naproxen
| Package NDC: | 21695-343-30 |
| Package Description: | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (21695-343-30) |
NDC Information of Naproxen
| NDC Code | 21695-343-30 |
| Proprietary Name | Naproxen |
| Package Description | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (21695-343-30) |
| Product NDC | 21695-343 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Naproxen |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100602 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | NAPROXEN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
